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Abstract 
The newborn infant with atypical genitalia presents a challenging clinical scenario and 
requires expert input. There have been appreciable advances in our knowledge of the 
underlying causes that may lead to a mere difference or a more serious disorder of sex 
development (DSD), the natural history of conditions, as well as the short and long-term 
complications of these conditions themselves, together with the clinical interventions that are 
associated with these conditions. With this information, the DSD expert can be more 
confident when discussing options with the parents of the newborn infant. By working within 
a multidisciplinary team, the expert should be able to support the family whilst individualising 
the management plan so that it is also cognizant of the shifts in societal attitudes and 
expectations around concepts of diversity and openness. It is, therefore, likely that the 
practice of assigning sex, especially in those cases where sex assignment is unclear on 
expert assessment, will continue to show temporal, social and geographical variations. It is 
imperative that clinical data for rare conditions such as these are collected in a standardized 
format and shared through a common registry so that any evidence that is used for future 
shifts in practice has a stronger foundation than that which is currently available. 
 
Introduction 
When sex development is affected in early life, the involved infant often presents with 
atypical genitalia in the neonatal period. This presentation raises the possibility of a disorder 
of sex development (DSD) (1). The underlying biological condition in a number of cases of 
atypical genitalia, especially those with a 46 XY karyotype who are raised as a boy, remains 
unclear. The newborn infant that has genitalia that are so atypical that a diagnosis cannot be 
reached at initial presentation, presents a problem of sex assignment and should be 
considered a clinical emergency. It is important to identify these scenarios as early as 
possible and to have a care pathway that can be quickly activated. The aim of this paper is to 
review the process of sex assignment and areas that are contentious and to consider future 
directions. 
 
Sex Development  
Sex development is a process that can be broadly divided into the development of the 
gonads and the development of the reproductive organs and the genitalia. This process is 
under the control of molecular networks of male- and female-specific gene expression, 
dosing and interaction (2). Presence of XY chromosomes triggers activation of the SRY 
gene, which initiates development of a testis, where the primary sex cords develop into 
Sertoli cells. Sertoli cells produce anti-Müllerian Hormone (AMH) which promotes the 
regression of the Müllerian ducts. Leydig cells form outside the testicular tubules and 
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produce testosterone, which stimulates the Wölffian duct to persist to form the epididymis, 
vas deferens and seminal vesicles. Under the influence of androgens, the genital tubercle 
differentiates and enlarges to become a penis, the urethral folds form the penile urethra, and 
labioscrotal swellings fuse to form the scrotum. In the absence of testicular development 
being switched on by the SRY gene on the Y chromosome, Wnt-4 signaling sustains oocyte 
and granulosa cell development, and suppresses Sertoli and Leydig cell differentiation. The 
Müllerian system of the embryo gives rise to the uterus, cervix, upper vagina, and fallopian 
tubes in the absence of AMH. In the absence of androgens, the phallus becomes a clitoris, 
the labioscrotal folds become the labia, and the urethra does not migrate to the tip of the 
phallus (2).  
 
Disorders of Sex Development  
“Disorders of sex development” is an umbrella term for a group of conditions that arise due to 
a biological variation in chromosomal, gonadal, or anatomic sex. The current classification of 
DSD in three subgroups, sex chromosome DSD, 46, XX DSD, and 46, XY DSD, was 
recommended by the international consensus group on management of intersex disorders in 
Chicago in 2005 (1). These disorders could be determined at different development stages of 
the life-cycle in fetuses or newborns with atypical external genitalia, dysgenetic gonads and 
internal genitalia. The term ‘DSD’, by itself, is not a diagnosis but a presentation 
characterised by a wide range of clinical features such as hypospadias (1 in 250 boys), 
ambiguous genitalia (1 in 4500 live births) and complete XX or XY sex reversal (1 in 20,000 
births) (3, 4, 5). Older children and adolescents may present with clinical features such as 
delayed puberty, unexpected virilization or gynaecomastia, infertility, or gonadal tumors. 
The first step in sexual differentiation is the activation of the SRY gene to trigger testicular 
development at 7–8 weeks of fetal development. When there is a mutation or deletion of 
SRY, or one of the early downstream genes in gonadal differentiation, then the gonads fail to 
mature into either ovary or testis and become nonfunctional streak gonads. Failure of 
testicular development leads to absent male hormones required for masculinization of both 
internal and external genitalia. This leads to regression of the Wölffian duct and preservation 
of the Müllerian duct. The external genitalia continue on the female developmental pathway, 
leading to a normal external female phenotype at birth. Whilst the vagina and uterus form 
normally in the absence of AMH, the formation of functioning ovaries requires the activation 
of critical ovarian development genes. 
 
In females with non-disjunction of the sex chromosomes, leading to the 45,X genotype 
(Turner syndrome), the primitive germ cells are displaced from the caudal yolk-sac into the 
indifferent gonad. Therefore absence of the second X chromosome leads to abnormal 
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development of the follicles. This in turn leads to premature senescence in early childhood. 
The germ cells undergo premature death, sometime between late foetal life and the first few 
years after birth. Early biopsy of the gonad, at birth or shortly afterwards, may show some 
primary follicles which degrade over the next few years. As a result, for patients with 45,X/46, 
XX mosaicism ovarian function may be occasionally sustained until later in life. In some rare 
forms of abnormal sex determination, there is complete sex reversal, with XY females or XX 
males. In the latter case, the common cause is translocation of a small segment of the Y 
chromosome, which includes the SRY gene, onto the X chromosome, usually at Xp11 .3. 
Currently this is identified by fluorescent in situ hybridisation (FISH) with a marker for the 
SRY gene (6). 
 
Factors that influence sex assignment at birth  
The approach to sex of rearing decisions in DSD patients has changed fundamentally over 
time and involves many factors. Influencing factors for sex assignment include diagnosis, 
genital appearance, fertility potential, therapeutic and surgical options and familial views or 
circumstances including cultural biases. When a specific diagnosis can be reached, 
recommendations for sex assignment can be based upon outcome data. The assessment of 
the genitalia must include a description and symmetry of the external genital development 
including degree of virilization, Prader staging and the presence and position of gonads. 
Asymmetry is primarily seen as a result of greater virilization of the labioscrotal fold derived 
structures on one side compared with the other. This commonly results in the appearance of 
one side more like a labial fold and the other like a hemi-scrotum. For underdeveloped male 
genitalia, the capacity to respond to exogenous androgen may be a challenging method for 
determining sex assignment given that there are no agreed norms. Parental backgrounds 
and expectations, broader family dynamics, social circumstance and ethnic or cultural 
influences must also be considered in each case. 
 
Temporal trends in attitudes  
The Chicago Consensus recommended that every affected child had the right to be assigned 
sex and generally sex assignment is performed soon after birth. However, most health care 
providers allow a period where notification of birth can be delayed. In some countries such as 
Australia, Bangladesh, Germany, India, New Zealand, Nepal and Pakistan, the sex of the 
child can be registered as undetermined and the calls for this category to be more widely 
available internationally as well as removing sex assignment from official documents is 
increasing. It is possible that the need for sex in official documents such as birth certificates 
or passports may have been driven by the need for sex to be a distinguishing marker of 
identification. With increasing availability of alternative forms of biometrics, the need to have 
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sex as a marker of identification may reduce over time. In some infants affected by DSD and 
especially those presenting with genital ambiguity, the issue of sex of rearing has been a 
debatable aspect of management. In 2006, it was stipulated that sex assignment cannot 
solely be based on genital appearance but should include the diagnosis, surgical options, 
replacement therapy, the potential for fertility, views of the family and circumstances relating 
to cultural approach(3). The presentation of DSD in the newborn when sex assignment is 
unclear has often been considered ‘a medical and social emergency’. Whilst it is true that 
such a presentation may signify life threatening conditions such as congenital adrenal 
hyperplasia, a label of emergency may lead to a hastened process with inadequate 
communication within the team or with the family. More recently, in some countries such as 
Germany, parents have been given the option to delay sex assignment for longer than was 
previously possible and this may help with the process of sex assignment. It remains to be 
further studied whether these shifts in policy reduce the stigma or isolation felt by the parents 
or the child (7). 
Recent data from the I-DSD Registry show that practice amongst specialist centres is also 
changing. Whereas in the past, infants with XY DSD (other than complete AIS) who had a 
very low external masculinization score (EMS) were raised as a girl, more recently, these 
infants are more likely to be raised as a boy (8). Whilst this shift in practice is guided by 
accumulating evidence of adverse psychosocial and psychosexual outcome in those raised 
as girls (9), there is a continuing need to gather evidence on long-term outcome in those who 
are now being raised as boys. Whilst it is generally believed that 46 XX infants with CAH 
should be raised as girls, with the availability of long-term outcome data, some experts have 
questioned this practice in those infants who are severely virilised at birth, advocating that a 
male sex of rearing may be more appropriate (10). 
 
Sex assignment  
The birth of a child with suspected DSD is a challenging situation for parents and health 
professionals (11). In many cases, a decision is made immediately after birth about the sex 
of the child. The possible course of future physical, emotional and sexual development of 
individuals with DSD must also be kept in mind, in order to make the right decision in 
childhood to achieve good lifelong outcomes for health, emotional and social development 
(12). The lack of knowledge about the relative contribution of biological (e.g., genes and 
prenatal sex hormone exposure) and non-biological influences (e.g., parental attitude, peer 
influences and cultural context) on gender development can make sex assignment more 
difficult. Prediction of adult gender identity is difficult in some conditions. Although there is no 
doubt that investigations are required in all infants with suspected DSD, there is less 
certainty about when investigations should be performed in those cases in which the 
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genitalia are less ambiguous. Expert opinion suggests that groups of infants who should be 
evaluated include those with female genitalia with atypical features, such as an enlarged 
clitoris, or those with male genitalia with atypical features (13, 14). Also evaluation may be 
necessary in those who have a family history of DSD or there is discordance between genital 
appearance and a prenatal karyotype. The health care team has the important role of 
evaluating the patient and informing the parents about the diagnosis, possible therapies, 
available outcome data as well as availability of support groups (12). Surgical possibilities, 
potential for fertility and the need for hormone replacement should also be taken into account 
when necessary.  
 
Geographical differences  
Society often plays a major role in the decision for sex assignment and the sex of rearing 
decision is often considered to be the parents’ right, obligation and responsibility. Strong 
social pressures influenced by cultural, traditional and economic factors persist in some 
social groups, where the male may have a dominant role in financial and social life. In such 
communities where a man is the traditional breadwinner, choosing the male gender is often 
considered to be more preferable for the affected offspring than the individual’s sexual 
potential (15, 16, 17). There are only a few reports about geographical differences in 
choosing sex of rearing. A recent study from India showed that seven infants who were 46, 
XX and had congenital adrenal hyperplasia (CAH) were raised as males because of family 
preference, older age of diagnosis and having a ‘good’ phallus (18). In such scenarios, the 
algorithm for sex assignment is over simplified and based on good or poor phallic 
development (19,20).  
 
Evidence of discontent with assigned sex  
It is not unusual that adults with DSD experience discontent with the assigned sex. This may 
be attributed to several reasons including medical interventions such as surgery or hormone 
replacement therapy, impact of delayed or precocious development, experience of 
stigmatization or psychological trauma, social expectation of gender role behavior and other 
coexisting mental health conditions. Some studies found that girls with CAH show 
masculinization of behavior, such as spatial orientation, visualization, targeting, personality, 
cognitive abilities, and sexuality (21, 22, 23). Others demonstrated a masculine bias on 
various personality traits supporting the determining role of parental steroids in sex-role 
identity (e.g., Detachment and Indirect Aggression Scales, Aggression and Stress Reaction 
Scales, Reinish’s Aggression Inventory) (24). Although women with CAH develop a female 
gender identity, gender dysphoria may be more common than in women without CAH (25). It 
was shown that five percent of adolescent and adult women with CAH suffer a form of 
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gender dysphoria contributing to the decision for sex re-assignment. The extent of sexual 
activity of women with CAH may also be lower when compared with the normal population 
(26). A recent literature review concluded that people who were 46 XX and extremely virilized 
due to CAH and who were reared male may enjoy satisfactory level of social and sexual 
function as male adults if they obtained optimal social support (27, 28). Prenatal androgen 
stimulation in girls with CAH results in different levels of virilization. The severity of the 
enzyme defect has influence on phenotype.  Sexual function and the quality of sexual life in 
women with CAH following genital surgery with clitoroplasty and vaginoplasty has been 
reported in several small group studies and many report dissatisfaction with clitoral surgery 
(29, 30, 31). Medically, the low birth rate in women with CAH may be due to the influence of 
low gonadotropins and high progesterone levels (32).  
 
Due to an androgen biosynthesis problem, children with 46, XY who have 5α reductase-Type 
2 deficiency or 17β-hydroxysteroid dehydrogenase-Type 3 deficiency are usually born with 
female-appearing or ambiguous genitalia. In general, these infants are raised as girls and at 
puberty, when they start to masculinize, transition to the male role has been described (33). 
An increased rate of sex change from the female to the male sex role has been seen in 
children and adolescents with genital malformation (agenesis of the penis, cloacal exstrophy) 
who grow up as girls and had a normal level of male hormones at birth (34). The increase in 
testosterone level after puberty thus seems to be an important factor in gender identity and 
consolidation in individuals with these conditions. It is also possible that testosterone 
exposure at critical prenatal stages may have also played a role. Cultural factors should be 
considered, because gender role change may also occur at different rates in different 
societies (1).  
 
In Complete Androgen Insensitivity Syndrome (CAIS) the complete female appearance at 
birth usually masks the condition completely and the infants are raised without any doubt as 
girls. These children display typical girl behavior and female gender development, with no 
signs of gender dysphoria (27, 34). However, it is possible that women with CAIS may be 
dissatisfied with their primary sex organs, even without observable gender atypical signs 
(35). The issue of insecurity based on their own body perception may arise due to 
discrepancy between gender role and karyotype. On the other hand, individuals with partial 
androgen insensitivity syndrome (PAIS) may develop gender dysphoria (36). Approximately 
25% of individuals with PAIS appear to develop gender dysphoria regardless of the sex they 
are reared as (37).  
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Many affected children with DSD undergo feminizing or masculinizing genitoplasties as well 
as gonadectomies. There are several reasons for these surgeries including aligning a child’s 
phenotype more closely with their sex of rearing, determining future fertility potential, and 
removing the risk of malignancy (38). In those undergoing feminizing surgeries (clitoroplasty 
and vaginoplasty) the total excision of the clitoris is no longer recommended.  The current 
approach is a clitoroplasty that preserves the glans and neurovascular bundle of the phallus 
for better genital sensation and orgasmic potential (39). The point of entry of the vagina into 
the urogenital sinus is important for the choice of vaginoplasty procedure. Novel methods for 
vaginoplasty include skin flap, sigmoid bowel, and pullthrough (36). Alternative interventions 
such as vaginal dilatation may also be preferred in some situations. The timing and the need 
for these procedures is increasingly debatable and is beyond the scope of this review on sex 
assignment. 
 
Recent investigations of outcomes of gonadectomy and vaginoplasty in girls and women 
affected by CAIS range from satisfaction with surgery (40,41) to preference for early surgery, 
to a lack of sexual desire/arousal and dyspareunia attributed to these procedures (42,43). 
Among the factors contributing to the high dissatisfaction with treatment in this subgroup are 
the lack of information provided to the patient about their condition and its management so 
that they can make an informed decision for themselves. It is unclear if improved surgical 
techniques have resulted in higher patient satisfaction, since age did not influence the 
satisfaction rates with surgery (42). On the other hand, women with 46, XY DSD without 
genitoplasty and born with female external genitalia were mostly satisfied with their vaginal 
length and clitoral arousal (44). However, a recent Dutch study with a mix of people with XY 
DSD and CAH reported impairment on the female sexual function index and were at risk of 
developing sexual dysfunction, non-operated patients with CAIS and complete gonadal 
dysgenesis were significantly more dissatisfied with sexual life than operated women with XY 
DSD or CAH. This study showed that a large proportion of women reported problems of 
coping with diagnosis, distress of infertility and suffering from societal ignorance (43, 44). It is 
therefore possible that these are the major contributory factors in the impairment of 
psychosexual and psychosocial life in XY DSD.  
 
Masculinizing surgeries for DSD include release of ventral chordee, hypospadias repair, 
gonadectomies and placement of prosthetic testes in the scrotum at puberty. Many studies 
have found that men with hypospadias repair in childhood still report at least some degree of 
dissatisfaction with their genital appearance and size, which may lead to psychosexual 
distress and jeopardize sexual well-being (45).  In 46 XY DSD with micropenis, it is not only 
the genital appearance, but also overall physical development – such as male development 
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and eventual breast growth - as is the case in PAIS – that can lead to a negative body image 
and impaired social interactions (46). Retrospectively, it is increasingly clear that 
masculinizing genitoplasty in severe cases of hypospadias may require many more 
procedures than feminizing genitoplasty and may also result in a poorer cosmetic outcome 
(46). In comparison to those who develop a male gender, patients with 46,XY DSD reared 
male who ultimately develop a female gender do not experience different cosmetic or 
functional outcomes from their genitoplasty (44). Postoperative complications (fistulae, 
urethral strictures and meatal stenosis and repeated surgical procedures are of particular 
prospective concern because of associated scarring and loss of tissue, as well as the 
estimated negative impact on sexual function (47). In addition, penile lengthening 
procedures, such as in hypospadias repair in men with penile deficiency, can only elongate 
the penis by an average of 1.5-2.5 cm. Whether or not a correlation exists between small 
penile length and dysfunctional penetrative intercourse remain unclear, although a penile 
length of more than 6-7 cm seems to constitute a premise for successful sexual contact (48, 
49, 50). Some authors described a few men with micropenis who reported a mutually 
satisfying sex life with their heterosexual partners (51, 52).  
 
Summary   
Differences in DSD management will result from a combination of traditional beliefs, folk 
remedies and prejudices, fed by rumour and discrimination and available healthcare 
resources and expertise (18). Nevertheless, it should be appreciated that people with DSD 
have the same desires as everyone else: to find a peer who will love them; to be a valuable 
part of society; to be comfortable with their body; to be able to have satisfactory sexual 
relations; to integrate into the community; and to trust their medical caregivers. More clinical 
studies as well as academic and public debate are needed to support people with DSD with 
sex assignment, gender identity development, atypical gender role behavior, sexual 
orientation and satisfaction with their own sexuality. It is debatable whether the 
dissatisfaction that people with DSD experience with the allocated sex of rearing is a gender 
identity disorder or not. People with DSD who are discontent may simply be showing an 
evolving discrepancy between the gender identity they experience and the sex of rearing 
which, in most cases was chosen by their carers at birth. All carers, parents and 
professionals, should be aware that possibility of dissatisfaction with the assigned sex, 
however small, does exist and centres that provide expert care should be prepared to 
support the patient and the family, if required.   
 
Finally, healthcare workers should share expertise and collaborate globally in prospective 
studies as it is essential to gain insight into the outcome of individuals affected by these rare 
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conditions. The variations in practice can be decreased through networks of clinical and 
research centers. Disease registries are playing a significant role in development and 
improvement of networks. Establishment of the DSD registry in 2007, initially as the ESPE 
DSD Registry, followed by the Euro-DSD Registry and currently as the I-DSD Registry, is a 
perfect example of how registries can evolve and also be used to address issues ranging 
from fundamental mechanisms to clinical practice and health care outcomes (8). It is likely 
that newly established international collaborations to generate sufficient numbers for the 
study of very rare disorders will provide better information on which new protocols can be 
developed. 
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